NORRIS MEDICINES LTD. (NORRIS)

BSE: ₹14.67
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Change in Management

Appointment of Internal Auditor w.e.f 30.05.2026

2026-05-30 16:45:50
Outcome Of Board Meeting Held Today I.E. 30Th May, 2026.

As per attachment.

2026-05-30 16:26:09
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th May, 2026.

As per attachment.

2026-05-30 16:17:42
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For Holding Board Meeting For Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Other Matters.

As per attachment.

2026-05-25 19:39:42
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

As per attachment.

2026-04-20 12:08:21
Closure of Trading Window

As per attachment.

2026-03-26 12:09:18
Outcome Of The Board Meeting Held On 14Th February, 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

As per attachment.

2026-02-14 16:41:44
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February, 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

As per attachment

2026-02-14 16:34:40
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 – Closure Of Case ID 223728 For Reclassification Of Promoter.

As per attachment.

2026-02-13 18:20:19
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements, 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31St, 2025 And Other Matters.

As per attachment.

2026-02-11 13:28:29

Quarterly Financials

Consolidated Standalone
No financial data available for Consolidated.

Yearly Financial Results

Consolidated Standalone
No yearly financial data available for Consolidated.